2 Small-Cap Biotechs That Soared Last Week
The stocks of Magenta Therapeutics (NASDAQ: MGTA) and Molecular Templates (NASDAQ: MTEM) bolted skywards last week, to the tune of 39% and 28% respectively.
Cutting-edge gene-editing therapies, chimeric antigen receptor T-cell (CAR-T) treatments, and stem cell transplants all require priming or conditioning regimens. Doctors today utilize older chemotherapy drugs or radiation, which often lead to infection or hospitalization. Magenta Therapeutics and Molecular Templates are among the companies seeking to develop less toxic, non-chemotherapy options for patients.
Image source: Getty Images.
Source Fool.com
